Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Report from the ELCC 2019 Congress, Geneva, April 10th-13th, 2019

Report from the ELCC 2019 Congress, Geneva, April 10th-13th, 2019 special issue ELCC 2019 ELCC 2019 Table of Contents S32 Preface S32 Current perspectives in EGFR-targeted therapy S35 Immunotherapy: analyses elucidating durvalumab & pembrolizumab activity S37 Encouragingfindings inNTRK-, ROS1- and ALK-positive lung cancer S40 Interview: Improving accuracy of lung cancer screening S41 Extensive-disease small-cell tumors: signals of activity S43 Interview: “We need chemotherapy when rapid responses are required” S43 Anti-angiogenic combinations excel in later lines Editorial Board: Alex A. Adjei, MD, PhD, Mayo Clinic, Department of Oncology, Rochester, Minnesota, USA Maria Rosario Garcia Campelo, MD, Lung Cancer and Thoracic Tumors, University Hospital Quirón A Coruña, La Coruña, Spain Federico Cappuzzo, MD, Medical Oncology Department, Ospedale Civile di Livorno, Livorno, Italy Wolfgang Hilbe, MD, Departement of Oncology, Hematology and Palliative Care, Wilhelminenspital, Vienna, Austria Frau Vera Hirsh, MD, McGill University, Health Centre, Montreal, Quebec, Canada Maximilian Hochmair, MD, 1. Interne Lungenabteilung, Otto-Wagner-Spital, Vienna, Austria Herbert H F Loong, MD, The Chinese University of Hong Kong, Department of Clinical Oncology, Hong Kong Massimo Di Maio, MD, National Institute of Tumor Research and Therapy, Foundation G. Pascale, Napoli, Italy Filippo de Marinis, MD, PhD, Director of the Thoracic Oncology Division at the European Institute of Oncology (IEO), Milan, Italy Barbara Melosky, MD, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png memo - Magazine of European Medical Oncology Springer Journals

Report from the ELCC 2019 Congress, Geneva, April 10th-13th, 2019

memo - Magazine of European Medical Oncology , Volume 12 (2) – May 24, 2019
Download PDF
14 pages

Loading next page...
 
/lp/springer-journals/report-from-the-elcc-2019-congress-geneva-april-10th-13th-2019-63BdqoyY7h

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © 2019 by Springer-Verlag GmbH Austria, part of Springer Nature
Subject
Medicine & Public Health; Oncology; Medicine/Public Health, general
ISSN
1865-5041
eISSN
1865-5076
DOI
10.1007/s12254-019-0498-1
Publisher site
See Article on Publisher Site

Abstract

special issue ELCC 2019 ELCC 2019 Table of Contents S32 Preface S32 Current perspectives in EGFR-targeted therapy S35 Immunotherapy: analyses elucidating durvalumab & pembrolizumab activity S37 Encouragingfindings inNTRK-, ROS1- and ALK-positive lung cancer S40 Interview: Improving accuracy of lung cancer screening S41 Extensive-disease small-cell tumors: signals of activity S43 Interview: “We need chemotherapy when rapid responses are required” S43 Anti-angiogenic combinations excel in later lines Editorial Board: Alex A. Adjei, MD, PhD, Mayo Clinic, Department of Oncology, Rochester, Minnesota, USA Maria Rosario Garcia Campelo, MD, Lung Cancer and Thoracic Tumors, University Hospital Quirón A Coruña, La Coruña, Spain Federico Cappuzzo, MD, Medical Oncology Department, Ospedale Civile di Livorno, Livorno, Italy Wolfgang Hilbe, MD, Departement of Oncology, Hematology and Palliative Care, Wilhelminenspital, Vienna, Austria Frau Vera Hirsh, MD, McGill University, Health Centre, Montreal, Quebec, Canada Maximilian Hochmair, MD, 1. Interne Lungenabteilung, Otto-Wagner-Spital, Vienna, Austria Herbert H F Loong, MD, The Chinese University of Hong Kong, Department of Clinical Oncology, Hong Kong Massimo Di Maio, MD, National Institute of Tumor Research and Therapy, Foundation G. Pascale, Napoli, Italy Filippo de Marinis, MD, PhD, Director of the Thoracic Oncology Division at the European Institute of Oncology (IEO), Milan, Italy Barbara Melosky, MD,

Journal

memo - Magazine of European Medical Oncology – Springer Journals

Published: May 24, 2019

There are no references for this article.